Orin Goldblum

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis

Journal of the American Academy of Dermatology · 2010 · Last of 5 authors · 130 citations

Baricitinib in patients with moderate-to-severe atopic dermatitis: Results from a randomized monotherapy phase 3 trial in the United States and Canada (BREEZE-AD5)

Journal of the American Academy of Dermatology · 2021 · 116 citations